Friedman Billings Resumes Coverage on Bed Bath & Beyond (BBBY)
More News related to BBBY
- 'Tis the Season to Pop the Question
- Wedbush Adds Bed Bath & Beyond (BBBY) to 'Best Ideas' List, Removes PetSmart (PETM)
- Trading Review for Kirkland's Inc. Issued by Beacon Equity
- UBS on Retail: Starts BBY, HD, AZO at Buy, KMX, ORLY, SPLS at Neutral
- Near Strangulation of Children Prompts Recall of Roman Shades by Louis Hornick & Co.; Sold Exclusively at Bed Bath & Beyond
More News related to New Coverage
- Janney Montgomery Scott Initiates Coverage on Calgon Carbon (CCC) with a Neutral
- Deutsche Bank Initiates Coverage on Digital Realty Trust (DLR) with a Buy; Attractive Long-Term Growth Prospects
- Bank of America Starts Rating Agencies Moody's (MCO) and McGraw-Hill (MHP) at Buy
- Jefferies Starts Under Armour (UA) at Buy
- Oppenheimer Starts Visa (V) and MasterCard (MA) at Outperform
Friedman Billings resumes coverage on Bed Bath & Beyond (Nasdaq: BBBY) with a Underperform rating. Price target $26.50.
Bed Bath & Beyond Inc. and subsidiaries is a chain of retail stores, operating under the names Bed Bath & Beyond (BBB), Christmas Tree Shops (CTS), Harmon and Harmon Face Values (Harmon) and buybuy BABY.
Related Categories
New CoverageStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
